BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Antares Pharma, Inc. 

161 Cheshire Lane
Suite 100
Plymouth  Minnesota  55441  U.S.A.
Phone: 800-328-3074-or-612-475-7700 Fax: 612-476-1009


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Antares Pharma, Inc. (ATRS) Announces Closing Of Public Offering Of Common Stock 5/12/2015 12:27:40 PM
Antares Pharma, Inc. (ATRS) Reports First Quarter 2015 Operating And Financial Results 5/11/2015 8:25:43 AM
Antares Pharma, Inc. (ATRS) To Present At The Bank of America (BAC) Merrill Lynch 2015 Healthcare Conference 5/7/2015 12:23:36 PM
Antares Pharma, Inc. (ATRS) To Host First Quarter 2015 Operating And Financial Results Conference Call 5/6/2015 10:45:04 AM
Antares Pharma, Inc. (ATRS) Announces Pricing Of Public Offering Of Common Stock 5/6/2015 7:26:09 AM
Antares Pharma, Inc. (ATRS) To Present At The Deutsche Bank (DB) 40th Annual Health Care Conference 4/30/2015 1:20:47 PM
Antares Pharma, Inc. (ATRS) Regains U.S. Marketing Rights To OTREXUP For Psoriasis Indication - Announces Termination Of LEO Pharma Marketing Agreement 4/27/2015 7:39:24 AM
Antares Pharma, Inc. (ATRS) Announces Settlement Of Patent Infringement Lawsuits 4/16/2015 8:49:47 AM
Antares Pharma, Inc. (ATRS) Announces FDA Approval Of TEV-TROPIN(R) 10 Mg (Human Growth Hormone) Needle-Free Injector 3/31/2015 6:39:46 AM
Antares Pharma, Inc. (ATRS) Reports Fourth Quarter And Full Year 2014 Operating And Financial Results 3/12/2015 12:05:56 PM
12345678910...